| Dr Gilberto L De Miranda, MD | |
|
6517 Taft St, Hollywood, FL 33024-4062 | |
| (954) 983-9191 | |
| (954) 983-1152 |
| Full Name | Dr Gilberto L De Miranda |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 33 Years |
| Location | 6517 Taft St, Hollywood, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316940943 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | ACN1208 (Florida) | Primary |
| 208D00000X | General Practice | 11202 (Puerto Rico) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cano Health, Llc | 1759565047 | 247 |
News Archive
AlphaCore Pharma, a biopharmaceutical company developing ACP-501 (rhLCAT) for the treatment of high risk atherosclerosis and serious lipid metabolism disorders, today announced the initiation of a Phase 1 study of ACP-501 in patients with stable coronary arterial disease.
Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory,has begun to significantly penetrate the Mexican healthcare market with the initial placement in 2010 of 40 iQ®200 Elite™ Automated Urine Microscopy Analyzers within one of the largest social security healthcare systems in Mexico.
The Washington Post offers a compelling example of the challenges the White House faces in its efforts to get its message out about the benefits of the health law. Meanwhile, the Boston Globe offers insights from former Centers for Medicare and Medicaid Services Administrator Donald Berwick about what the administration needs to do in order to have more success with this message.
Omega Healthcare Investors, Inc. today announced its results of operations for the quarter ended March 31, 2010. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three months ended March 31, 2010 of $33.4 million or $0.38 per common share.
› Verified 3 days ago
| Entity Name | Medical Consultants Of Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619169810 PECOS PAC ID: 6002988847 Enrollment ID: O20080710000450 |
News Archive
AlphaCore Pharma, a biopharmaceutical company developing ACP-501 (rhLCAT) for the treatment of high risk atherosclerosis and serious lipid metabolism disorders, today announced the initiation of a Phase 1 study of ACP-501 in patients with stable coronary arterial disease.
Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory,has begun to significantly penetrate the Mexican healthcare market with the initial placement in 2010 of 40 iQ®200 Elite™ Automated Urine Microscopy Analyzers within one of the largest social security healthcare systems in Mexico.
The Washington Post offers a compelling example of the challenges the White House faces in its efforts to get its message out about the benefits of the health law. Meanwhile, the Boston Globe offers insights from former Centers for Medicare and Medicaid Services Administrator Donald Berwick about what the administration needs to do in order to have more success with this message.
Omega Healthcare Investors, Inc. today announced its results of operations for the quarter ended March 31, 2010. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three months ended March 31, 2010 of $33.4 million or $0.38 per common share.
› Verified 3 days ago
| Entity Name | Cano Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689901688 PECOS PAC ID: 1759565047 Enrollment ID: O20110411000829 |
News Archive
AlphaCore Pharma, a biopharmaceutical company developing ACP-501 (rhLCAT) for the treatment of high risk atherosclerosis and serious lipid metabolism disorders, today announced the initiation of a Phase 1 study of ACP-501 in patients with stable coronary arterial disease.
Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory,has begun to significantly penetrate the Mexican healthcare market with the initial placement in 2010 of 40 iQ®200 Elite™ Automated Urine Microscopy Analyzers within one of the largest social security healthcare systems in Mexico.
The Washington Post offers a compelling example of the challenges the White House faces in its efforts to get its message out about the benefits of the health law. Meanwhile, the Boston Globe offers insights from former Centers for Medicare and Medicaid Services Administrator Donald Berwick about what the administration needs to do in order to have more success with this message.
Omega Healthcare Investors, Inc. today announced its results of operations for the quarter ended March 31, 2010. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three months ended March 31, 2010 of $33.4 million or $0.38 per common share.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gilberto L De Miranda, MD 6517 Taft St, Hollywood, FL 33024-4062 Ph: (954) 983-9191 | Dr Gilberto L De Miranda, MD 6517 Taft St, Hollywood, FL 33024-4062 Ph: (954) 983-9191 |
News Archive
AlphaCore Pharma, a biopharmaceutical company developing ACP-501 (rhLCAT) for the treatment of high risk atherosclerosis and serious lipid metabolism disorders, today announced the initiation of a Phase 1 study of ACP-501 in patients with stable coronary arterial disease.
Early data suggest ETC-1002, a drug that regulates lipid and carbohydrate metabolism, had a significant impact on cholesterol levels and improved factors believed to contribute to cardio-metabolic diseases, say researchers from the Methodist DeBakey Heart & Vascular Center, the Baylor College of Medicine, and Esperion Therapeutics, Inc., who are presenting their work at the 2012 American College of Cardiology Scientific Session in Chicago.
IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory,has begun to significantly penetrate the Mexican healthcare market with the initial placement in 2010 of 40 iQ®200 Elite™ Automated Urine Microscopy Analyzers within one of the largest social security healthcare systems in Mexico.
The Washington Post offers a compelling example of the challenges the White House faces in its efforts to get its message out about the benefits of the health law. Meanwhile, the Boston Globe offers insights from former Centers for Medicare and Medicaid Services Administrator Donald Berwick about what the administration needs to do in order to have more success with this message.
Omega Healthcare Investors, Inc. today announced its results of operations for the quarter ended March 31, 2010. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three months ended March 31, 2010 of $33.4 million or $0.38 per common share.
› Verified 3 days ago
Dr. Bradley John Schulte, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 3501 Johnson St, Hollywood, FL 33021 Phone: 954-673-3793 | |
Tatyana Travkina, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 3501 Johnson St, Hollywood, FL 33021 Phone: 954-265-5423 | |
Dr. John J Mcgoohan Iv, D.O, General Practice Medicare: Not Enrolled in Medicare Practice Location: 210 S Federal Hwy Ste 403, Hollywood, FL 33020 Phone: 954-929-3449 Fax: 954-929-2001 | |
Dr. Keyla Diaz - Medina, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 3700 Washington St Ste 500b, Hollywood, FL 33021 Phone: 954-967-6110 | |
Ramon Alberto Berenguer, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 7050 Taft St, Hollywood, FL 33024 Phone: 954-399-9014 Fax: 754-802-3009 | |
Andres Ozual, MD General Practice Medicare: May Accept Medicare Assignments Practice Location: 4801 Hollywood Blvd Ste B, Hollywood, FL 33021 Phone: 954-927-5905 Fax: 844-546-1497 | |
Dr. Giovanna A Baldarrago, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 1610 Sheridan St, Hollywood, FL 33020 Phone: 954-922-7400 Fax: 954-925-1327 |